Advertisement
Monthly long-acting cabotegravir and rilpivirine are noninferior to daily regimens for patients with HIV-1

Long-Acting Regimen Noninferior to Daily ART for HIV-1

0
Monthly long-acting cabotegravir and rilpivirine noninferior in two randomized controlled trials

American Academy of Dermatology, March 1-5

0
The American Academy of Dermatology The annual meeting of the American Academy of Dermatology was held from March 1 to 5 in Washington,...
Ten confirmed cases of mumps

Mumps Outbreak Reported at Temple University

0
CDC says more than 2,000 cases of mumps in U.S. last year, 58 cases reported in January of this year
An environmental intervention of probiotic sanitation can effectively alter hospital microbiota

Probiotic Sanitation Cuts Antimicrobial Resistance in Hospitals

0
Impact seen in lower use of antibiotics, costs tied to health care-associated infections
Staphylococcus aureus infections are still a concern in the United States

Hospital-Onset MRSA Decreased From 2002 to 2015

0
S. aureus infections also dropped overall at VA medical centers after MRSA prevention program initiation
Recommendations have been developed for management of adults with ulcerative colitis; the American College of Gastroenterology clinical guideline was published online Feb. 21 in the American Journal of Gastroenterology.

Recommendations Developed for Ulcerative Colitis Management

0
Guidelines address diagnosis, treatment, and overall clinical management of adult patients
In only the second known case worldwide

Second Man HIV-Free After Stem Cell Transplant

0
Donor had double copy of gene mutation that confers natural resistance to HIV
Google

AAP: Social Media Companies Must Curb Spread of Vaccine Myths

0
American Academy of Pediatrics is reaching out to social media companies
In what probably came as a surprise to many

FDA Commissioner Dr. Scott Gottlieb Resigns

0
Gottlieb's signature effort has been tighter scrutiny, enforcement of e-cigarette industry
Recommending pneumococcal vaccination for all 50-year-olds prevents the most disease in underserved minorities and the general population

Pneumococcal Vaccination at Age 50 Prevents the Most Disease

0
But cost of giving pneumococcal vaccines to all 50-year-olds exceeds $250,000 per QALY